Luca Franceschini
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 24
- Multiple Myeloma Research and Treatments 15
- Chronic Myeloid Leukemia Treatments 5
- Acute Myeloid Leukemia Research 3
- Genetics 10
- Chronic Lymphocytic Leukemia Research 6
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
- Co-authors
- Maria Cantonetti (11 shared papers)Manuela Rizzo (11 shared papers)Maria Teresa Voso (4 shared papers)Tiziana Ottone (2 shared papers)Alberto Bergamini (1 shared paper)Ettore Squillaci (1 shared paper)Elmo Mannarino (1 shared paper)Massimo Raffaele Mannarino (1 shared paper)
- Journals
- Blood (3 papers)British Journal of Haematology (3 papers)Cancers (3 papers)Annals of Hematology (2 papers)Current Medical Research and Opinion (1 paper)
- Partner nations
- ItalyUnited StatesMalaysia
In The Last Decade
Luca Franceschini
33 papers receiving 740 citations
Peers
Comparison fields: 5 of 68
- Hematology 527
- Genetics 109
- Oncology 246
- Molecular Biology 333
- Nephrology 21
Countries citing papers authored by Luca Franceschini
This map shows the geographic impact of Luca Franceschini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Franceschini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Franceschini more than expected).
Fields of papers citing papers by Luca Franceschini
This network shows the impact of papers produced by Luca Franceschini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Franceschini. The network helps show where Luca Franceschini may publish in the future.
Co-authors
The 25 scholars most cited alongside Luca Franceschini, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 185 | |
| 2 | 2013 | 184 | |
| 3 | 2019 | 70 | |
| 4 | 2020 | 50 | |
| 5 | 2021 | 37 | |
| 6 | 2016 | 27 | |
| 7 | 2016 | 26 | |
| 8 | 2014 | 22 | |
| 9 | 2018 | 22 | |
| 10 | 2020 | 18 | |
| 11 | 2012 | 11 | |
| 12 | 2018 | 10 | |
| 13 | 2014 | 9 | |
| 14 | 2018 | 7 | |
| 15 | 2025 | 7 | |
| 16 | 2013 | 6 | |
| 17 | 2015 | 6 | |
| 18 | 2015 | 6 | |
| 19 | 2015 | 6 | |
| 20 | 2022 | 5 |
About Luca Franceschini
Luca Franceschini is a scholar working on Hematology, Genetics, Oncology, Periodontics and Rheumatology, having authored 39 papers that have together received 749 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (15 papers), Chronic Lymphocytic Leukemia Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Alkaline Phosphatase Research Studies (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Peptidase Inhibition and Analysis (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Hematology (527 citations), Genetics (109 citations), Oncology (246 citations), Molecular Biology (333 citations) and Nephrology (21 citations). Luca Franceschini has collaborated with scholars based in Italy, United States and Malaysia. Frequent co-authors include Maria Cantonetti, Manuela Rizzo, Maria Teresa Voso, Tiziana Ottone, Alberto Bergamini, Ettore Squillaci, Elmo Mannarino, Massimo Raffaele Mannarino, Francesco Pisani and Amirhossein Sahebkar. Their work appears in journals such as Blood, British Journal of Haematology, Cancers, Annals of Hematology and Current Medical Research and Opinion.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.